Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release

Epigallocatechin gallate (EGCG) has been recognized as the most prominent green tea extract due to its healthy influences. The high instability and low bioavailability, however, strongly limit its utilization in food and drug industries. This work, for the first time, develops amorphous solid disper...

Full description

Bibliographic Details
Main Authors: Yizheng Cao, Jing Teng, Jon Selbo
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/10/4/88
id doaj-42432eaafa6c4ea8a4e40f7fd8fe4bf1
record_format Article
spelling doaj-42432eaafa6c4ea8a4e40f7fd8fe4bf12020-11-25T03:25:09ZengMDPI AGPharmaceuticals1424-82472017-11-011048810.3390/ph10040088ph10040088Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled ReleaseYizheng Cao0Jing Teng1Jon Selbo2Solid State Chemical Information (SSCI), a Division of Albany Molecular Research Inc., West Lafayette, IN 47906, USASolid State Chemical Information (SSCI), a Division of Albany Molecular Research Inc., West Lafayette, IN 47906, USASolid State Chemical Information (SSCI), a Division of Albany Molecular Research Inc., West Lafayette, IN 47906, USAEpigallocatechin gallate (EGCG) has been recognized as the most prominent green tea extract due to its healthy influences. The high instability and low bioavailability, however, strongly limit its utilization in food and drug industries. This work, for the first time, develops amorphous solid dispersion of EGCG to enhance its bioavailability and physical stability. Four commonly used polymeric excipients are found to be compatible with EGCG in water-dioxane mixtures via a stepwise mixing method aided by vigorous mechanical interference. The dispersions are successfully generated by lyophilization. The physical stability of the dispersions is significantly improved compared to pure amorphous EGCG in stress condition (elevated temperature and relative humidity) and simulated gastrointestinal tract environment. From the drug release tests, one of the dispersions, EGCG-Soluplus® 50:50 (w/w) shows a dissolution profile that only 50% EGCG is released in the first 20 min, and the remains are slowly released in 24 h. This sustained release profile may open up new possibilities to increase EGCG bioavailability via extending its elimination time in plasma.https://www.mdpi.com/1424-8247/10/4/88epigallocatechin gallateamorphous solid dispersionphysical stabilitycontrolled releasebioavailability
collection DOAJ
language English
format Article
sources DOAJ
author Yizheng Cao
Jing Teng
Jon Selbo
spellingShingle Yizheng Cao
Jing Teng
Jon Selbo
Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
Pharmaceuticals
epigallocatechin gallate
amorphous solid dispersion
physical stability
controlled release
bioavailability
author_facet Yizheng Cao
Jing Teng
Jon Selbo
author_sort Yizheng Cao
title Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
title_short Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
title_full Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
title_fullStr Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
title_full_unstemmed Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release
title_sort amorphous solid dispersion of epigallocatechin gallate for enhanced physical stability and controlled release
publisher MDPI AG
series Pharmaceuticals
issn 1424-8247
publishDate 2017-11-01
description Epigallocatechin gallate (EGCG) has been recognized as the most prominent green tea extract due to its healthy influences. The high instability and low bioavailability, however, strongly limit its utilization in food and drug industries. This work, for the first time, develops amorphous solid dispersion of EGCG to enhance its bioavailability and physical stability. Four commonly used polymeric excipients are found to be compatible with EGCG in water-dioxane mixtures via a stepwise mixing method aided by vigorous mechanical interference. The dispersions are successfully generated by lyophilization. The physical stability of the dispersions is significantly improved compared to pure amorphous EGCG in stress condition (elevated temperature and relative humidity) and simulated gastrointestinal tract environment. From the drug release tests, one of the dispersions, EGCG-Soluplus® 50:50 (w/w) shows a dissolution profile that only 50% EGCG is released in the first 20 min, and the remains are slowly released in 24 h. This sustained release profile may open up new possibilities to increase EGCG bioavailability via extending its elimination time in plasma.
topic epigallocatechin gallate
amorphous solid dispersion
physical stability
controlled release
bioavailability
url https://www.mdpi.com/1424-8247/10/4/88
work_keys_str_mv AT yizhengcao amorphoussoliddispersionofepigallocatechingallateforenhancedphysicalstabilityandcontrolledrelease
AT jingteng amorphoussoliddispersionofepigallocatechingallateforenhancedphysicalstabilityandcontrolledrelease
AT jonselbo amorphoussoliddispersionofepigallocatechingallateforenhancedphysicalstabilityandcontrolledrelease
_version_ 1724598790381371392